Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening

Johanna Huchting
Arjen Weller
Moyra Schweizer
Mona Brandt
Jan Heering
Maria Kuzikov
Markus Wolf
Jeanette Reinshagen
Markus A. Queisser
Philip Gribbon
Andrea Zaliani
Ole Pless
Aimo Kannt

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.

Log in to save this article

Abstract

No abstract available

Version published to 10.1021/acsptsci.5c00195
Jul 20, 2025
Version published to 10.1101/2025.03.06.641606v1 on bioRxiv
Mar 11, 2025

Prospective discovery of LasB inhibitors by integrating generative design, free energy ranking, and experimental validation

This article has 6 authors:
1. Alejandro Martínez León
2. Angeliki Vgenopoulou
3. Gwenaëlle Jézéquel
4. Andreas M Kany
5. Anna KH Hirsch
6. Jochen S Hub
This article has no evaluationsLatest version Oct 13, 2026
AnewDDE: An Agentic Drug Discovery Engine for Biomolecular Interaction Modelling and Closed-Loop Design

This article has 2 authors:
1. Anew Labs Team
2. Kai Liu
This article has no evaluationsLatest version Sep 25, 2026
Structure-function analysis of PI3K signalling cascade base editing screens in cancer cells

This article has 19 authors:
1. Katrina McCarten
2. Barbara Abreu
3. Benoit Baillif
4. Lisa Koob
5. Jong Sook Ahn
6. Cansu Dincer
7. Julian Esselborn
8. Emre Karakoc
9. R. Frederick Ludlow
10. John Lyons
11. Gabriele Picco
12. Mamta Sharma
13. Marcel L. Verdonk
14. Mark Wade
15. Samantha Walker
16. Alexander Watterson
17. Matthew A. Coelho
18. Thomas G. Davies
19. Mathew J. Garnett
This article has no evaluationsLatest version Sep 14, 2026